Your browser doesn't support javascript.
loading
A Post-Marketing Surveillance Study to Evaluate the Safety Profile of AlvotereⓇ (Docetaxel) in Iranian Patients Diagnosed with Different Types of Cancers Receiving Chemotherapy.
Shahi, Farhad; Vafaeezadeh, Farahnaz; Ansarinejad, Nafiseh; Ahmadi, Alireza; Shahriari-Ahmadi, Ali; Ghazizadeh, Alireza; Vahedian Ardakani, Hassanali; Ravanbod, Mohammad Reza; Seifi, Sharareh; Foratyazdi, Mohammad; Mousavi, Seyed Asadollah; Rajabi Vahid, Mansour; Rahimi, Hossein; Seghatoleslami, Mohammad; Razavi, Seyed Mohsen; Pourkhani, Amir Houshang; Babakhani, Davoud; Anjidani, Nassim.
Afiliación
  • Shahi F; Department of Medical Oncology, Tehran University of Medical Sciences, Tehran, Iran.
  • Vafaeezadeh F; Department of Medical Oncology, Tehran University of Medical Sciences, Tehran, Iran.
  • Ansarinejad N; Department of Hematology and Oncology, Iran University of Medical Sciences, Tehran, Iran.
  • Ahmadi A; Department of Oncology, School of Medicine, Hamadan University of Medical Sciences, Hamadan, Iran.
  • Shahriari-Ahmadi A; Department of Hematology and Oncology, Iran University of Medical Sciences, Tehran, Iran.
  • Ghazizadeh A; Medicine Department of Hematology-Medical Oncology, Rafsanjan University of Medical Sciences, Rafsanjan, Iran.
  • Vahedian Ardakani H; Department of Oncology, Medicine Shahid Sadoughi University of Medical Sciences, Yazd, Iran.
  • Ravanbod MR; Department of Hematology and Oncology, Bushehr University of Medical Sciences, Bushehr, Iran.
  • Seifi S; Chronic Respiratory Diseases Research Center, National Research Institute of Tuberculosis and Lung Diseases, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
  • Foratyazdi M; Department of Oncology, Medicine Shahid Sadoughi University of Medical Sciences, Yazd, Iran.
  • Mousavi SA; Department of Medical Oncology, Tehran University of Medical Sciences, Tehran, Iran.
  • Rajabi Vahid M; Department of Hematology and Oncology, Zanjan University of Medical Sciences, Zanjan, Iran.
  • Rahimi H; Department of Internal Medicine, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
  • Seghatoleslami M; Health research institute, Research Center of Thalassemia & Hemoglobinopathy, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.
  • Razavi SM; Department of Hematology and Oncology, Iran University of Medical Sciences, Tehran, Iran.
  • Pourkhani AH; Oncology and Hematology, Clinical Research Development Center, Sayad Shirazi Hospital, Golestan University Of Medical Sciences, Gorgan, Iran.
  • Babakhani D; Department of Medical Oncology, Tehran University of Medical Sciences, Tehran, Iran.
  • Anjidani N; Head of Medical Department, Orchid Pharmed Company, Tehran, Iran.
Curr Ther Res Clin Exp ; 96: 100659, 2022.
Article en En | MEDLINE | ID: mdl-35035631
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Clinical_trials / Diagnostic_studies / Screening_studies Idioma: En Revista: Curr Ther Res Clin Exp Año: 2022 Tipo del documento: Article País de afiliación: Irán
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Clinical_trials / Diagnostic_studies / Screening_studies Idioma: En Revista: Curr Ther Res Clin Exp Año: 2022 Tipo del documento: Article País de afiliación: Irán